Jupiter Life Line Hospitals Reports Strong FY26 Results, Approves Shareholder Actions

Jupiter Life Line Hospitals announced its audited consolidated financial results for the fiscal year ended March 31, 2026. The company reported revenue of ₹1,542.15 crore and a profit after tax of ₹194.19 crore. Standalone revenue for the period was ₹1,197.62 crore, with standalone profit after tax at ₹191.38 crore.

During a Board of Directors meeting on May 15, 2026, several key decisions were made. An interim dividend of ₹1 per equity share was declared for FY 2025-26. Additionally, the Board approved a significant corporate action: the sub-division of existing equity shares in a 1:5 ratio. This move is subject to necessary shareholder and regulatory approvals.

The interim dividend offers shareholders a direct cash return. The proposed stock split aims to improve the stock's liquidity and affordability, making it more accessible to a broader base of retail investors. Following the split, the face value of existing equity shares will reduce from ₹10 to ₹2, effectively multiplying the number of shares held by five. The stock price is expected to adjust proportionally downwards.

The Board also ratified key leadership changes, including the appointment of Dr. Ajay Thakker as Chairman & Whole-Time Director.

Jupiter Life Line Hospitals operates multi-specialty hospitals in India, with major facilities in Thane, Nagpur, and Indore. The company went public in September 2023. It competes in the Indian healthcare sector with established players like Apollo Hospitals Enterprise, Fortis Healthcare, Max Healthcare Institute, and Narayana Hrudayalaya.

Investors will be watching for the company to announce the date for its Annual General Meeting (AGM). Shareholders should note May 22, 2026, as the record date for dividend entitlement. Progress on obtaining shareholder and regulatory approvals for the stock split, along with any future guidance on expansion plans shared at the AGM, will also be key.